Skip to main content

and
  1. No Access

    Article

    Growth factor Midkine is involved in the pathogenesis of renal injury induced by protein overload containing endotoxin

    Growth factor Midkine (MK), which expresses on endothelial cells and renal proximal tubules, has been implicated in inflammation-related kidney diseases such as ischemic reperfusion-induced tubulointerstitial ...

    Kiyonari Kato, Tomoki Kosugi, Waichi Sato in Clinical and Experimental Nephrology (2011)

  2. No Access

    Article

    A rare case of acute kidney injury associated with autoimmune hemolytic anemia and thrombocytopenia after long-term usage of oxaliplatin

    Oxaliplatin is effective in advanced colorectal cancer and is known to have relatively few side effects, such as hemolysis and renal toxicity. We report a case of acute kidney injury (AKI) after treatment with...

    Isao Ito, Yasuhiko Ito, Masashi Mizuno in Clinical and Experimental Nephrology (2012)

  3. No Access

    Article

    Efficacy and safety of human adipose tissue-derived mesenchymal stem cells for supporting hematopoiesis

    We have demonstrated that adipose tissue-derived mesenchymal stem cells (ADSCs) from mice are capable of reconstituting the hematopoietic microenvironment, and facilitate hematopoiesis more effectively than bo...

    Satoshi Nishiwaki, Takayuki Nakayama, Shigeki Saito in International Journal of Hematology (2012)

  4. Article

    Open Access

    Prevalence of anti-phospholipase A2 receptor antibodies in Japanese patients with membranous nephropathy

    Membranous nephropathy (MN) is the leading cause of nephrotic syndrome in adults. Anti-M-type phospholipase A2 receptor (anti-PLA2R) antibodies are found in most patients with idiopathic MN (iMN) worldwide, bu...

    Shin’ichi Akiyama, Mari Akiyama, Enyu Imai in Clinical and Experimental Nephrology (2015)

  5. No Access

    Article

    Investigation on the benefits of mycophenolate mofetil and therapeutic drug monitoring in the treatment of Japanese patients with lupus nephritis

    Mycophenolate mofetil (MMF) is recommended as a first-line immunosuppressant to treat lupus nephritis (LN). Prognosis and therapeutic response in LN are known to vary depending on race. We investigated the ben...

    Takayuki Katsuno, Takenori Ozaki, Takaya Ozeki in Clinical and Experimental Nephrology (2018)